![]() dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. | ![]() EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. | ||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 1987 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Morrisville, US HQ | Locations Watertown, US HQ |
Employees | Employees 908 | Employees 172 | Employees 8453% increase |
Valuation ($) | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) 617.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $31.4m (FY, 2025) |
Net income | Net income ($397.9m) (FY, 2025) | Net income N/A | Net income ($232m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 1.9b | Total funding raised $ 208m | Total funding raised $ 40m |

dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities.
View company
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View company